Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Vaccination using the adenoviral vector COVID-19 vaccine ChAdOx1 nCoV-19 (AstraZeneca) has been associated with rare vaccine-induced immune thrombotic thrombocytopenia (VITT). Affected patients test strongly positive in platelet factor 4 (PF4)/polyanion enzyme immunoassays (EIAs), and serum-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Thomas, Ulm, Lena, Holtfreter, Silva, Schönborn, Linda, Kuhn, Sven Olaf, Scheer, Christian, Warkentin, Theodore E., Bröker, Barbara M., Becker, Karsten, Aurich, Konstanze, Selleng, Kathleen, Hübner, Nils-Olaf, Greinacher, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129797/
https://www.ncbi.nlm.nih.gov/pubmed/33988688
http://dx.doi.org/10.1182/blood.2021012217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129797/
https://www.ncbi.nlm.nih.gov/pubmed/33988688
http://dx.doi.org/10.1182/blood.2021012217

Ejemplares similares